Breaking News
January 23, 2019 - Unique data combination helps FinnGen researchers to fund links between genetic factors and health
January 23, 2019 - Parents’ mental health problems associated with reactive attachment disorder in children
January 23, 2019 - Graphene Flagship project studies impact of graphene and related materials on our health
January 23, 2019 - The connection between the Pope and contraceptive pills
January 23, 2019 - Prior dengue infection could protect children from symptomatic Zika
January 23, 2019 - VISTA checkpoint implicated in pancreatic cancer immunotherapy resistance
January 23, 2019 - The Tiny Camera That Could Revolutionize Cardiovascular Surgery
January 23, 2019 - Peptide isolated from soil fungi has antitumor and antibacterial properties
January 23, 2019 - TGen identifies polio-like virus as potential cause of Acute Flaccid Myelitis outbreak
January 23, 2019 - Migrants and refugees do not bring disease and are at greater health risk themselves says WHO
January 23, 2019 - Examing the effects of menopause in workplace
January 23, 2019 - Enemy number 1 – Air pollution and climate change top of WHO agenda
January 23, 2019 - Two Positive Phase III studies of Tafenoquine for the Radical Cure of Plasmodium vivax Malaria Published in The New England Journal of Medicine
January 23, 2019 - World Trade Center responders at increased risk for head and neck cancers
January 23, 2019 - Low-sugar diet leads to significant improvement in nonalcoholic fatty liver disease in boys
January 23, 2019 - Chaos in bodily regulation can optimize our immune system, finds study
January 23, 2019 - Short, text-based exercises can increase happiness for adults recovering from substance use disorders
January 23, 2019 - Body size may have greater influence on women’s lifespan than men
January 23, 2019 - Groundbreaking tool helps visualize neuronal activity with near-infrared light
January 23, 2019 - Holocaust survivors with PTSD and their offspring exhibit more unhealthy behavior patterns
January 23, 2019 - Scientists discover new genetic mutations causing inherited deaf-blindness
January 23, 2019 - UC team designs new naloxone-dispensing smart device
January 23, 2019 - Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP
January 23, 2019 - Brain activity shows development of visual sensitivity in autism
January 23, 2019 - Two hour gap between dinner and sleep is overrated says Japanese research
January 23, 2019 - Fear and embarrassment are causing smear test numbers to plummet
January 23, 2019 - Protein-secreting device implanted in epileptic rats reduces seizures, improves cognition
January 23, 2019 - Reintroduction project recovers current wild population of green turtle in Cayman Islands
January 23, 2019 - Cancer survivors face greater financial burden related to medical bills
January 23, 2019 - PSA screening reduces prostate cancer deaths by 30%
January 23, 2019 - LSTM receives grant to help improve health of people living in informal settlements
January 23, 2019 - Hemochromatosis Mutation Linked to Other Morbidity
January 23, 2019 - Why early diagnosis of autism should lead to early intervention
January 23, 2019 - Aspirin May Lower Stroke Risk in Women with History of Preeclampsia
January 23, 2019 - Exposure to certain chemicals may be linked to decrease in blood pressure during pregnancy
January 23, 2019 - Bowel cancer on the rise among younger Australians
January 23, 2019 - Scientists have reversed memory loss in a mouse model of Alzheimer’s
January 23, 2019 - Defective molecular master switch could lead to age-related macular degeneration
January 23, 2019 - Researchers identify how concussions may contribute to seizures
January 23, 2019 - Short interval between last meal of the day and bedtime may not affect blood glucose levels
January 23, 2019 - Still Too Many Highway Deaths Tied to Speeding
January 23, 2019 - Prenatal valproate exposure linked to increased ADHD risk
January 23, 2019 - Compound identified that may help treat heart failure
January 23, 2019 - Undiagnosed Asthma in Urban Adolescents May Be Common
January 23, 2019 - Study describes metabolism of intestinal microbiota in babies for the first time
January 22, 2019 - Study links concussions to development of epilepsy
January 22, 2019 - Specialist-led hospital bereavement service may help restrain legal action after difficult deaths
January 22, 2019 - Genetic study reveals possible new routes to treating osteoarthritis
January 22, 2019 - Blood test may detect early signs of lung-transplant rejection
January 22, 2019 - Blood marker could aid in early prediction of Alzheimer’s progression
January 22, 2019 - Orthodontic treatment does not guarantee future dental health
January 22, 2019 - Rutgers researchers discover cause of bone loss in people with joint replacements
January 22, 2019 - Diversity among rural Africans extends to their gut microbiomes
January 22, 2019 - Newly developed biological system lets cells to create self-curving cornea
January 22, 2019 - VTv Therapeutics Announces Publication of Comprehensive Data in Science Translational Medicine Detailing the Discovery and Clinical Development of TTP399, including Results of Phase 2 AGATA Study
January 22, 2019 - about one in three adults with prediabetes has arthritis
January 22, 2019 - A look at how data is democratizing health care
January 22, 2019 - Alcohol-Linked Disease Overtakes Hep C As Top Reason For Liver Transplant
January 22, 2019 - Researchers identify new genes linked with age-related macular degeneration
January 22, 2019 - MPFI researchers identify synaptic logic for connections between two brain hemispheres
January 22, 2019 - New approach to reduce toxic protein production in ALS
January 22, 2019 - New study extends our knowledge of the link between miRNAs and cancer
January 22, 2019 - Asthma, eczema are not barriers to active lifestyle in teenagers
January 22, 2019 - Genetic changes may predict likelihood of relapse in breast cancer patients
January 22, 2019 - Antiepileptic drug use by people with Alzheimer’s disease linked to accumulation of hospital days
January 22, 2019 - IUPUI researcher receives $2.85 million grant to find ways to improve bone strength
January 22, 2019 - Precision medicine can help keep astronauts healthy during deep space missions
January 22, 2019 - Detecting signs of neurodegeneration earlier and more accurately
January 22, 2019 - Mouse studies challenge ‘inhibition’ theory of autism
January 22, 2019 - SSB launches BIOSTAT RM TX single-use bioreactor for producing consistent quality cellular products
January 22, 2019 - Experimental drug can positively modify key characteristic behavior in FXS patients
January 22, 2019 - Low-Income Women Lack Menstrual Hygiene Supplies
January 22, 2019 - Better mouse model built to enable precision-medicine research for Alzheimer’s
January 22, 2019 - Molecular profiling of precancerous lung lesions could lead to early detection and new treatments
January 22, 2019 - Genetic factors influence where fat is stored in our bodies
January 22, 2019 - The Psychology Behind Sticking to Your New Year’s Resolutions
January 22, 2019 - Scientists aim to find genetic causes of developmental abnormalities in the vagina and uterus
January 22, 2019 - New survey reveals scale of preventative healthcare challenge in the UK
January 22, 2019 - Looming Global Crisis Means People’s Diets Must Change: Experts
January 22, 2019 - Excessive social media use is comparable to drug addiction
Patient Outcomes of Prostate Cancer with Whole Slide Imaging

Patient Outcomes of Prostate Cancer with Whole Slide Imaging

image_pdfDownload PDFimage_print

An interview with Dr. Anil Parwani, discusses how whole slide imaging of prostate cancer sections is helping to inform pathologists and improve patient outcomes.

Prostate cancer is often a devastating diagnosis for any patient to receive, please give an overview of the factors that contribute to the severity of the condition.

Prostate cancer is one of the most common cancers in men in the Western Hemisphere. It is more common in older men, but occasionally younger patients present with prostate cancer. Even at a younger age, the risk of cancer is not clear; we do not have a good understanding of how it progresses. Cancers that appear to have a similar morphology might behave differently between patients.

In some patients the cancer progresses very quickly, so we need a good risk assessment score to separate out these patients.  When the cancer spreads to the bone and liver, the outcome for patients is poor. In a certain percentage of cases, the cancer is caught at a late stage, which can be devastating for patients.

What research do you and your lab conduct in prostate cancer? What are the end goals?

As a pathologist, my goal is to find good diagnostic assays that can help us stratify patients according to risk. We would like to find a model way of looking at a patient’s cancer and its morphology to see if we can identify anything unique in that patient’s biopsy that can separate them out and be predictive of how they will progress and what their outcome will be. We would then like to be able to offer therapeutic options to the patient based on this.

How do you and your lab approach your research into prostate cancer?

We have been assessing prostate cancer slides from patients for the last seven or eight years. We have been creating an image database of known prostate cancers and how the patients do. We have been looking at this retrospectively to see if we can understand patterns we can apply to the prostate cancer for a better future diagnosis.

Our goal is to find better predictors of outcomes, such as the microenvironment of the cancer, how the cancer is growing in the stroma or what surrounds the prostate cancer cells. We would like to see if there are any unique signatures that we can decipher in this digital image.

Also, within a prostate biopsy, there might be benign mimickers of cancer, which can lead to misdiagnosis of cancer and overtreatment. We would like to find diagnostic features in the digitized slide that will help us separate the benign mimickers from variants of prostate cancer.

At the Digital Pathology Scanning Center, we have scanned over 800,000 slides over the last year and about ten percent of those are prostate cancer slides. We are creating one of the largest databases of prostate cancer tissues and the goal is to use this incredible resource to answer many of these questions.

What are the challenges associated with scaling up the digital pathology to such a large scale?

One challenge is being able to get a glass slide that is produced in the lab and convert that into a digital image. It requires a lot of streamlining and standardization of the processes. People have been scanning slides for many years, but when you start to do it on a large scale in a clinical lab, you have to pay very careful attention to detail and the standardization of the processes.

You have to follow rules and regulations, because these are patient materials. When these materials are digitized, and images are produced, we want to make sure that the image is a replica of the glass slide. We have to validate that process. We have to look at a glass slide diagnosis, compare it to a digital diagnosis and make sure that they are no different.

We also need to have downtime processes to cater for if the system goes down. Being able to function in a clinical setting requires teamwork. Just one or two people in the pathology department could not do it. We have to start working with multiple outside stakeholders, the IT department, the financial department, for example, which requires an incredible effort.

What are the unique challenges to standardizing workflows and scanning large prostate sections?

In our institute, we perform full-mount processing of prostate slides. When a patient has a biopsy, they are processed in the standard way to produce a standard slide. For the full mounts, we take the whole prostate. We ink it, fix it and then then obtain many sections of the whole tissue.

We put those into a large cassette that is processed, and paraffin blocks are made. From those paraffin blocks we make very thin, unstained slides which are then stained with H&E. One of the challenges that is unique to scanning such large slides is the need for special equipment. You need special scanners; not every whole slide imaging scanner can accommodate these large slides.

How has the TissueScope LE 120 affected the digital pathology lab at The James Cancer Hospital? What are the advantages and limitations?

The TissueScope scanner is optimized for whole mount slides, but it can also accommodate standard-sized slides as well. We like it because we are required to place whole mount tissue in special 2 by 3 slides and this scanner enables us to do that.

It enables us to mix and match to use standard slides, full mounts and it is even capable of scanning a slide up to 6 by 8, which is a very unique feature of the system. We can accommodate a large, high-throughput scanning workflow, all whilst maintaining good image quality. It is a very versatile, easy-to-use system that can scan a standard slide in less than a minute.

How important is the reliability of the tissue scanner and the image quality of the samples that are produced?

It is extremely important, you want a system that can be optimized for your workflow, with an image quality that replicates the original sample and one that is reliable in performance and throughput. Image calibration and scanning need to be consistently high quality and you want to know you can walk away without issues.  

The TissueScope, along with the other systems in our lab, allows us to continuously scan slides, without any interruptions. This system also has z-stacking capabilities, which is something other systems do not have.

The image quality is also really good, the images are very sharp, clear and crisp. We are at the stage of assessing image quality and validating this for clinical use now. We are looking at glass slide diagnosis in 60 cases and after a washout period of two weeks, pathologists will make a diagnosis based on the images taken and we will compare that to the original glass slide diagnosis.

What does the future hold for your research?

The key thing for the future is to continue scanning high quality images from patients with prostate and other cancers so we can start interrogating them for specific features such as stromal inflammation and the microenvironment of the tumor.

It is a case of continuing to get the image set more annotated and more curated, as well as continuing to obtain follow-up data on these patients because that is how we are going to build image-based signatures for patient stratification and find diagnostic clues that will distinguish between benign mimickers and variants of cancer.

We need to continue this journey of understanding pathology, patterns and how this applies to the grading, diagnosis and outcome of these patients.

What do you see as the future of digital pathology and how it will affect your work and the work of others in your field?

I think the future of digital pathology is very bright in terms of how far we have come from taking one hour to scan a slide to today, where systems can take less than a minute to scan a slide.  Those slides can then be made available to experts worldwide for a second opinion, for example, and, to researchers for analysis and the development of deep learning algorithms.

It will not be long before more labs start to digitize their slides, and this will become the standard way of making a diagnosis in pathology. In the future there will be no “digital pathology,” – it will just be a standard part of pathology and the pathology lab.

Where can readers find more information?

About Dr. Anil Parwani, M.D., PhD, MBA

Professor of Pathology and Biomedical Informatics
The Ohio State University

Anil Parwani is a Professor of Pathology and Biomedical Informatics at The Ohio State University. He also serves as the Director of Division of Pathology Informatics and Digital Pathology, Department of Pathology. Dr. Parwani has sub-speciality training in Genitourinary Pathology.

His pathology practice is focused in GU and he has research interests in benign mimickers and unusual variants of prostate carcinoma, diagnostic and prognostic markers in GU pathology, and molecular classification of renal cell carcinoma and bladder carcinoma.

Dr. Parwani has expertise in the area of Anatomical Pathology Informatics including design of quality assurance tools, tissue banking informatics, clinical and research data integration and mining, synoptic reporting in anatomical pathology, clinical applications of whole slide imaging, digital imaging, telepathology, image analysis and lab automation and workflow processes such as barcoding and voice recognition.

Dr. Parwani has published extensively and has authored over 300 peer-reviewed articles in major scientific journals as well as numerous book chapters and is also the editor of several books. He currently serves as an editor-in-chief of Journal of Pathology Informatics and Diagnostic Pathology.

Tagged with:

About author

Related Articles